论文部分内容阅读
目的:对强肝胶囊联合熊去氧胆酸胶囊治疗慢性乙型肝炎的临床效果展开对比分析。方法:将48例慢性乙型肝炎患者分为治疗组和对照组,各24例,比较治疗效果。结果:两组患者临床治疗总有效率分别为87.50%和62.50%,比较差异有统计学意义(P<0.05);治疗组患者治疗后ALT、AST和TBIL肝功能指标均显著低于对照组和治疗前的,差异有一定统计学意义(P<0.05)。结论:在治疗慢性乙型肝炎临床上强肝胶囊联合熊去氧胆酸胶囊获得良好临床效果。
Objective: To compare and analyze the clinical effect of Qiang-Gan capsule combined with ursodeoxycholic acid capsule in the treatment of chronic hepatitis B. Methods: 48 patients with chronic hepatitis B were divided into treatment group and control group, 24 cases in each group. The therapeutic effects were compared. Results: The total effective rates of clinical treatment in two groups were 87.50% and 62.50%, respectively, with statistical significance (P <0.05). The indexes of ALT, AST and TBIL in the treatment group were significantly lower than those in the control group Before treatment, the difference was statistically significant (P <0.05). Conclusion: The clinical efficacy of Qianggan Capsule combined with ursodeoxycholic acid capsule in the treatment of chronic hepatitis B has achieved good clinical results.